Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126210283 | 12621028 | 3 | F | 20160909 | 20160804 | 20160915 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062416 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126210283 | 12621028 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 5 MG, BID | Y | AA97824A, 1357083 | 202155 | 5 | MG | BID | |||||
| 126210283 | 12621028 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 7.5 MG, QD | Y | 0 | 7.5 | MG | QD | ||||||
| 126210283 | 12621028 | 3 | SS | MESTINON | PYRIDOSTIGMINE BROMIDE | 1 | Unknown | 30 MG, UNK | Y | 0 | 30 | MG | |||||||
| 126210283 | 12621028 | 4 | SS | LOVASTATIN. | LOVASTATIN | 1 | Unknown | 20 MG, UNK | Y | 0 | 20 | MG | |||||||
| 126210283 | 12621028 | 5 | SS | VITAMINS /00067501/ | VITAMINS | 1 | Unknown | UNK, QD | Y | 0 | QD | ||||||||
| 126210283 | 12621028 | 6 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126210283 | 12621028 | 1 | Cerebrovascular accident prophylaxis |
| 126210283 | 12621028 | 2 | Product used for unknown indication |
| 126210283 | 12621028 | 3 | Product used for unknown indication |
| 126210283 | 12621028 | 4 | Product used for unknown indication |
| 126210283 | 12621028 | 5 | Product used for unknown indication |
| 126210283 | 12621028 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126210283 | 12621028 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126210283 | 12621028 | Myasthenia gravis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126210283 | 12621028 | 1 | 20160519 | 20160727 | 0 |